THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $7,252,000 | +49.3% | 656,296 | 0.0% | 0.23% | +49.4% |
Q3 2021 | $4,857,000 | -49.0% | 656,296 | 0.0% | 0.16% | -49.7% |
Q2 2021 | $9,529,000 | +2.3% | 656,296 | +43.8% | 0.31% | -3.1% |
Q1 2021 | $9,313,000 | +14.9% | 456,296 | 0.0% | 0.32% | +12.3% |
Q4 2020 | $8,108,000 | +83.7% | 456,296 | +52.9% | 0.28% | +72.7% |
Q3 2020 | $4,413,000 | -8.1% | 298,470 | +30.4% | 0.16% | -9.8% |
Q2 2020 | $4,803,000 | -9.2% | 228,836 | 0.0% | 0.18% | -23.4% |
Q1 2020 | $5,288,000 | +73.5% | 228,836 | +94.4% | 0.24% | +107.8% |
Q4 2019 | $3,048,000 | +239.4% | 117,725 | +155.4% | 0.12% | +194.9% |
Q3 2019 | $898,000 | +240.2% | 46,101 | +470.3% | 0.04% | +290.0% |
Q3 2018 | $264,000 | +44.3% | 8,083 | 0.0% | 0.01% | +42.9% |
Q2 2018 | $183,000 | -6.6% | 8,083 | 0.0% | 0.01% | -12.5% |
Q1 2018 | $196,000 | – | 8,083 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
Baupost Group | 4,200,021 | $35,616 | 0.98% |
Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |